Are you Dr. Farooqui?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 39 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1801 W Taylor St
Outpatient Care Center (Mc 771)
Chicago, IL 60612Phone+1 312-996-2242
Summary
- Dr. Mohammed Farooqui, DO is an oncologist in Chicago, Illinois. He is currently licensed to practice medicine in Illinois.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2008 - 2011
University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 2005 - 2008
Texas College of Osteopathic MedicineClass of 2005
Certifications & Licensure
IL State License 2005 - 2026
Clinical Trials
- Ofatumumab-based Induction Chemoimmunotherapy in Previously Untreated Patients With CLL/SLL Start of enrollment: 2010 Jul 01
Publications & Presentations
PubMed
- 302 citationsIbrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial.Mohammed Farooqui, Janet Valdez, Sabrina Martyr, Georg Aue, Nakhle S. Saba
The Lancet. Oncology. 2015-02-01 - 63 citationsClinical and biological implications of target occupancy in CLL treated with the BTK inhibitor acalabrutinib.Clare Sun, Pia Nierman, Ellen K. Kendall, Jean Cheung, Michael Gulrajani
Blood. 2020-07-02 - 249 citationsClonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia.Inhye E. Ahn, Chingiz Underbayev, Adam Albitar, Sarah E. M. Herman, Xin Tian
Blood. 2017-03-16
